Mechanisms of Ceramide-Mediated Neurodegeneration

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Alzheimer's Disease

• Publication date

  2009-04-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3233/JAD-2009-0983PMID 19387107PMCID PMC4550322
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Deregulation of sphingolipid metabolism in Alzheimer's disease.

  2010cited by this paper
• Hepatic Ceramide May Mediate Brain Insulin Resistance and Neurodegeneration in Type 2 Diabetes and Non-alcoholic Steatohepatitis

  2009cited by this paper
• Brain Insulin-Like Growth Factor and Neurotrophin Resistance in Parkinson's Disease and Dementia with Lewy Bodies: Potential Role of Manganese Neurotoxicity

  2009cited by this paper
• Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme

  2008cited by this paper
• Long‐chain ceramide is elevated in presenilin 1 (PS1M146V) mouse brain and induces apoptosis in PS1 astrocytes

  2008cited by this paper
• Regulation and functions of sphingosine kinases in the brain.

  2008cited by this paper
• Limited Alzheimer-Type Neurodegeneration in Experimental Obesity and Type 2 Diabetes Mellitus

  2008influential reference
• Characterization of Ceramide Synthase 2

  2008cited by this paper
• Updating the effects of fatty acids on skeletal muscle

  2008cited by this paper
• The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice.

  2008cited by this paper
• Models for non-alcoholic fatty liver disease: a link with vascular risk.

  2008cited by this paper
• Protection from High Fat Diet-induced Increase in Ceramide in Mice Lacking Plasminogen Activator Inhibitor 1*

  2008influential reference
• Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis.

  2008cited by this paper
• How insulin receptor substrate proteins regulate the metabolic capacity of the liver--implications for health and disease.

  2008cited by this paper
• Free fatty acids and skeletal muscle insulin resistance

  2008cited by this paper
• Non-alcoholic fatty liver disease and the metabolic syndrome: an update.

  2008cited by this paper
• Altered lipid metabolism in brain injury and disorders.

  2008cited by this paper
• Ethanol impaired neuronal migration is associated with reduced aspartyl-asparaginyl-β-hydroxylase expression

  2008cited by this paper
• Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytess⃞s⃞ The online version of this article (available at http://www.jlr.org) contains supplementary data in the form of three figures. Published, JLR Papers in Press, October 18, 2007.

  2008cited by this paper
• Sphingolipid signaling pathways as potential therapeutic targets in gliomas.

  2007cited by this paper
• Gene Expression Alterations in the Sphingolipid Metabolism Pathways during Progression of Dementia and Alzheimer’s Disease: A Shift Toward Ceramide Accumulation at the Earliest Recognizable Stages of Alzheimer’s Disease?

  2007cited by this paper
• Insulin‐like growth factor‐1‐dependent maintenance of neuronal metabolism through the phosphatidylinositol 3‐kinase–Akt pathway is inhibited by C2‐ceramide in CAD cells

  2007cited by this paper
• Regulation of insulin receptor function

  2007cited by this paper
• Insulin-induced differentiation and modulation of neuronal thread protein expression in primitive neuroectodermal tumor cells is linked to phosphorylation of insulin receptor substrate-1

  2007cited by this paper
• Free fatty acids and insulin resistance

  2007cited by this paper
• Adipose Tissue Inflammation and Increased Ceramide Content Characterize Subjects With High Liver Fat Content Independent of Obesity

  2007cited by this paper
• NGF-cholinergic dependency in brain aging, MCI and Alzheimer's disease.

  2007cited by this paper
• Lipid mediators of insulin resistance.

  2007cited by this paper
• Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study

  2007cited by this paper
• Insulin and insulin-like growth factor resistance with neurodegeneration in an adult chronic ethanol exposure model.

  2007cited by this paper
• Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease

  2006cited by this paper
• Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms

  2006cited by this paper
• Diabetes mellitus and dementia.

  2006cited by this paper
• Intracerebral streptozotocin model of type 3 diabetes: Relevance to sporadic Alzheimer's disease

  2006influential reference
• Ceramides in insulin resistance and lipotoxicity.

  2006influential reference
• Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: Relevance to Alzheimer's disease

  2006cited by this paper
• Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease

  2006cited by this paper
• Chronic gestational exposure to ethanol causes insulin and IGF resistance and impairs acetylcholine homeostasis in the brain

  2006cited by this paper
• Serum Adipokine and Ghrelin Levels in Nonalcoholic Steatohepatitis

  2006cited by this paper
• Mammalian Lass6 and its related family members regulate synthesis of specific ceramides.

  2005cited by this paper
• Acid Ceramidase Overexpression Prevents the Inhibitory Effects of Saturated Fatty Acids on Insulin Signaling*

  2005cited by this paper
• Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: Link to brain reductions in acetylcholine

  2005cited by this paper
• Clinical aspects of inflammation in Alzheimer's disease

  2005cited by this paper
• Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?

  2005cited by this paper
• The role of inflammation in Alzheimer's disease.

  2005cited by this paper
• Alzheimer-associated neuronal thread protein mediated cell death is linked to impaired insulin signaling

  2004cited by this paper
• Fat storage in pancreas and in insulin-sensitive tissues in pathogenesis of type 2 diabetes

  2004cited by this paper
• Beneficial Effects of Tumor Necrosis Factor-α Inhibition by Pentoxifylline on Clinical, Biochemical, and Metabolic Parameters of Patients with Nonalcoholic Steatohepatitis

  2004cited by this paper
• Ceramide synthesis and metabolism as a target for cancer therapy.

  2004cited by this paper
• Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin.

  2004cited by this paper
• Down syndrome and beta-amyloid deposition

  2004cited by this paper
• Model of nonalcoholic steatohepatitis.

  2004cited by this paper
• Connection of lipid peroxide oxidation with the sphingomyelin pathway in the development of Alzheimer's disease.

  2004cited by this paper
• Potential role of PTEN phosphatase in ethanol‐impaired survival signaling in the liver

  2003cited by this paper
• Nitric Oxide Synthase-3 Overexpression Causes Apoptosis and Impairs Neuronal Mitochondrial Function: Relevance to Alzheimer's-Type Neurodegeneration

  2003cited by this paper
• Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes.

  2003cited by this paper
• Ceramide stabilizes beta-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid beta-peptide biogenesis.

  2003cited by this paper
• Withdrawal: Ceramide stabilizes β-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid β-peptide biogenesis

  2003cited by this paper
• Ethanol Impairs Insulin-stimulated Neuronal Survival in the Developing Brain

  2003cited by this paper
• Lack of Neurodegeneration in Transgenic Mice Overexpressing Mutant Amyloid Precursor Protein Is Associated with Increased Levels of Transthyretin and the Activation of Cell Survival Pathways

  2002cited by this paper
• Oxygen Free Radical Injury Is Sufficient to Cause Some Alzheimer-Type Molecular Abnormalities in Human CNS Neuronal Cells

  2000cited by this paper
• Lethal forebrain ischemia stimulates sphingomyelin hydrolysis and ceramide generation in the gerbil hippocampus.

  2000cited by this paper
• Molecular abnormalities of the brain in Down syndrome: relevance to Alzheimer's neurodegeneration.

  1999cited by this paper
• Oxidative Alterations in Alzheimer's Disease

  1999cited by this paper
• Long Chain Ceramides Activate Protein Phosphatase-1 and Protein Phosphatase-2A

  1999cited by this paper
• Molecular abnormalities of the brain in Down syndrome: relevance to Alzheimer's neurodegeneration.

  1999cited by this paper
• Stimulation of DNA synthesis by natural ceramide 1-phosphate.

  1997cited by this paper
• Sphingomyelinases in cell regulation.

  1997influential reference
• Sphingolipid metabolism and cell growth regulation

  1996cited by this paper
• Ethanol inhibits insulin receptor substrate-1 tyrosine phosphorylation and insulin-stimulated neuronal thread protein gene expression.

  1995cited by this paper
• Multiple insulin-responsive elements regulate transcription of the GAPDH gene.

  1992cited by this paper

• Linagliptin Attenuates the Adverse Effects of a High-Sugar Diet on Insulin Sensitivity, Hippocampal Oxidative Stress, and Cognitive Function in Rats.

  2026cites this paper
• The role of intermittent fasting in the treatment of cognitive dysfunction in type 2 diabetes mellitus

  2025cites this paper
• Brain insulin resistance mediated cognitive impairment and neurodegeneration: Type-3 diabetes or Alzheimer’s Disease

  2025cites this paper
• Assessing the critical role of ceramide in the pathogenesis of Alzheimer's disease and its clinical significance.

  2025cites this paper
• Exercise training enhances myokine release and reduces brain insulin resistance: insights into muscle-CNS metabolic cross-talk

  2025cites this paper
• The Conceivable Role of Metabolic Syndrome in the Pathogenesis of Alzheimer’s Disease: Cellular and Subcellular Alterations in Underpinning a Tale of Two

  2025cites this paper
• Insulin Resistance, a Risk Factor for Alzheimer’s Disease: Pathological Mechanisms and a New Proposal for a Preventive Therapeutic Approach

  2024cites this paper
• A review of the mechanisms of abnormal ceramide metabolism in type 2 diabetes mellitus, Alzheimer’s disease, and their co-morbidities

  2024cites this paper
• Body roundness index and cognitive function in older adults: a nationwide perspective

  2024cites this paper
• A narrative review about cognitive impairment in Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD): Another matter to face through a holistic approach

  2024cites this paper
• Differential temporal therapies with pharmacologically targeted mitochondrial fission/fusion protect the brain against acute myocardial ischemia-reperfusion injury in prediabetic rats: The crosstalk between mitochondrial apoptosis and inflammation.

  2023cites this paper
• Type 2 Diabetes and Alzheimer’s Disease: The Emerging Role of Cellular Lipotoxicity

  2023cites this paper
• Hydroxyquinoline sulfanilamide ameliorates STZ-induced hyperglycemia-mediated amyleoid beta burden and memory impairment in adult mice

  2023cites this paper
• Therapeutic Effects of Myriocin in Experimental Alcohol-Related Neurobehavioral Dysfunction and Frontal Lobe White Matter Biochemical Pathology

  2022cites this paper
• Intestinal Microbiota Remodeling Protects Mice from Western Diet-Induced Brain Inflammation and Cognitive Decline

  2022cites this paper
• Plasma multi-omics analysis reveals very long chain ceramides as validated biomarkers of Friedreich's ataxia

  2022cites this paper
• Type 2 diabetes mellitus augments Parkinson's disease risk or the other way around: facts, challenges and future possibilities.

  2022cites this paper
• Potential neurotoxic activity of diverse molecules released by astrocytes.

  2022cites this paper
• Effect of Obesity in Memory and Cognition

  2022cites this paper
• Insulin and Its Key Role for Mitochondrial Function/Dysfunction and Quality Control: A Shared Link between Dysmetabolism and Neurodegeneration

  2022cites this paper
• Pharmacological Targeting of Mitochondrial Fission and Fusion Alleviates Cognitive Impairment and Brain Pathologies in Pre-diabetic Rats

  2022cites this paper
• Genome–microbiome interplay provides insight into the determinants of the human blood metabolome

  2022cites this paper
• The interplay among oxidative stress, brain insulin resistance and AMPK dysfunction contribute to neurodegeneration in type 2 diabetes and Alzheimer disease.

  2021cites this paper
• NOX4 promotes ferroptosis of astrocytes by oxidative stress-induced lipid peroxidation via the impairment of mitochondrial metabolism in Alzheimer's diseases

  2021cites this paper
• Role of PAR-4 in Ceramide-Inducible Effects in Neurodegeneration

  2021cites this paper
• Potential new therapeutic target for Alzheimer's disease: Glucagon‐like peptide‐1

  2021cites this paper
• The brain as an insulin-sensitive metabolic organ

  2021cites this paper
• Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review.

  2020cites this paper
• Targeting the Liver-Brain Axis with Hop-Derived Flavonoids Improves Lipid Metabolism and Cognitive Performance in Mice.

  2020cites this paper
• Insulin resistance and obesity

  2020cites this paper
• Insulin resistance and Alzheimer’s disease

  2020cites this paper
• Obesity and Alzheimer’s disease: Molecular bases

  2020cites this paper
• Targeting Oxidative Stress Reduction and Inhibition of HDAC1, MECP2, and NF-kB Pathways in Rats With Experimentally Induced Hyperglycemia by Administration of Thymus marshallianus Willd. Extracts

  2020cites this paper
• Neurodegenerative Pathways in Alzheimer’s Disease: A Review

  2020cites this paper
• The Full Spectrum of Alzheimer's Disease Is Rooted in Metabolic Derangements That Drive Type 3 Diabetes.

  2019cites this paper
• Ceramides and sphingosine-1-phosphate as potential markers in diagnosis of ischaemic stroke.

  2019cites this paper
• Insulin Resistance and Oligodendrocyte/Microvascular Endothelial Cell Dysfunction as Mediators of White Matter Degeneration in Alzheimer’s Disease

  2019cites this paper
• Insulin Resistance and Oxidative Stress in the Brain: What’s New?

  2019influential citation
• Links Between Obesity-Induced Brain Insulin Resistance, Brain Mitochondrial Dysfunction, and Dementia

  2018influential citation
• The 20-Year Voyage Aboard the Journal of Alzheimer's Disease: Docking at ‘Type 3 Diabetes’, Environmental/Exposure Factors, Pathogenic Mechanisms, and Potential Treatments

  2018cites this paper
• The locus coeruleus neurotoxin, DSP4, and/or a high sugar diet induce behavioral and biochemical alterations in wild-type mice consistent with Alzheimers related pathology

  2018cites this paper
• Lipidomic Profiles in Diabetes and Dementia

  2017cites this paper
• Altered temporal lobe white matter lipid ion profiles in an experimental model of sporadic Alzheimer's disease

  2017cites this paper
• The role of melatonin in the onset and progression of type 3 diabetes

  2017cites this paper
• The Heart and Mind Connection: Biomarkers of Cognitive Response to Exercise in Coronary Artery Disease

  2017cites this paper
• Acid Ceramidase Deficiency in Mice Results in a Broad Range of Central Nervous System Abnormalities.

  2017cites this paper
• Cigarette Smoke-Induced Alterations in Frontal White Matter Lipid Profiles Demonstrated by MALDI-Imaging Mass Spectrometry: Relevance to Alzheimer’s Disease

  2016cites this paper
• Metabolic parameters and cognitive function in a cohort of older diabetic patients

  2016cites this paper
• Alcoholic Beverage and Insulin Resistance–Mediated Degenerative Diseases of Liver and Brain: Cellular and Molecular Effects

  2016cites this paper
• Spinal Cord Injury Causes Chronic Liver Pathology in Rats

  2015cites this paper
• Differential Sphingolipid and Phospholipid Profiles in Alcohol and Nicotine-Derived Nitrosamine Ketone-Associated White Matter Degeneration.

  2015cites this paper
• Impact of Metabolic Control on Cognitive Function and Health-Related Quality of Life in Older Diabetics

  2014cites this paper
• Brain metabolic dysfunction at the core of Alzheimer's disease.

  2014cites this paper
• Impaired insulin signaling and mechanisms of memory loss.

  2014cites this paper
• Relationships between diabetes and cognitive impairment.

  2014cites this paper
• Effects of insulin gene dosage on body weight and glucose homeostasis

  2014cites this paper
• Insulin Resistance and Metabolic Failure Underlie Alzheimer Disease

  2013cites this paper
• Alcohol-Related Liver Disease: Roles of Insulin Resistance, Lipotoxic Ceramide Accumulation, and Endoplasmic Reticulum Stress

  2013cites this paper
• Contribution of Phospholipid, Sphingolipids, and Cholesterol‐Derived Lipid Mediators in the Pathogenesis of Metabolic Syndrome and Neurological Disorders

  2013cites this paper
• MicroRNA transport: A new way in cell communication

  2013cites this paper
• Slow Excitotoxicity in Alzheimer's Disease

  2013cites this paper
• Hyperinsulinemia drives diet-induced obesity independently of brain insulin production.

  2012cites this paper
• Metabolic derangements mediate cognitive impairment and Alzheimer's disease: role of peripheral insulin resistance diseases

  2012cites this paper
• Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease.

  2012cites this paper
• Alcohol, insulin resistance and the liver–brain axis

  2012cites this paper
• Metabolic derangements mediate cognitive impairment and Alzheimer's disease: role of peripheral insulin-resistance diseases.

  2012cites this paper
• High fat diet induced hepatic steatosis and insulin resistance: Role of dysregulated ceramide metabolism

  2012cites this paper
• Ceramide profiles in the brain of rats with diabetes induced by streptozotocin

  2012cites this paper
• Dihydroceramide desaturase and dihydrosphingolipids: debutant players in the sphingolipid arena.

  2012cites this paper
• Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimer's Disease

  2012cites this paper
• Sphingolipids: critical players in Alzheimer's disease.

  2012cites this paper
• Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimer's Disease

  2012cites this paper
• Triangulated Mal-Signaling in Alzheimer's Disease: Roles of Neurotoxic Ceramides, ER Stress, and Insulin Resistance Reviewed

  2012cites this paper
• Ceramide and Ceramide 1 Phosphate in the Brain

  2011cites this paper
• Insulin Resistance, Cognitive Impairment and Neurodegeneration: Roles of Nitrosamine Exposure, Diet and Lifestyles

  2011cites this paper
• Endocrine aspects of healthy brain aging.

  2010cites this paper
• Ceramide-Mediated Insulin Resistance and Impairment of Cognitive-Motor Functions

  2010influential citation
• Early limited nitrosamine exposures exacerbate high fat diet-mediated type 2 diabetes and neurodegeneration

  2010influential citation
• Insulin resistance and Alzheimer's disease.

  2009cites this paper
• Nitrosamine exposure exacerbates high fat diet-mediated type 2 diabetes mellitus, non-alcoholic steatohepatitis, and neurodegeneration with cognitive impairment

  2009influential citation
• Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis.

  2009cites this paper
• The Liver-Brain Axis of Alcohol-Mediated Neurodegeneration: Role of Toxic Lipids

  2009cites this paper